DTwP-hepatitis B vaccine - LG Life Sciences

Drug Profile

DTwP-hepatitis B vaccine - LG Life Sciences

Alternative Names: Combined CTwP-HB vaccine - LG Life Sciences; DTwP-hep B vaccine - LG Life Sciences; DTwP-HepB - LG Life Sciences; Euforavac; Euforvac; LBVW0101

Latest Information Update: 08 Oct 2015

Price : $50

At a glance

  • Originator LG Life Sciences
  • Class Bacterial vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 28 Aug 2015 Preregistration for Tetanus (Prevention) in China (IM)
  • 28 Aug 2015 Preregistration for Pertussis (Prevention) in China (IM)
  • 28 Aug 2015 Preregistration for Hepatitis B (Prevention) in China (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top